end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedLiabilitiesAndOtherLiabilities,AccruedProfessionalFeesCurrent,AdditionalPaidInCapitalCommonStock,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AssetsFairValueDisclosure,CapitalExpendituresIncurredButNotYetPaid,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ConversionOfStockAmountConverted1,ConvertiblePreferredStockSharesIssuedUponConversion,DeferredCosts,DeferredCostsCurrent,DeferredRevenueCurrent,DeferredRevenueNoncurrent,DepositsAssetsNoncurrent,Depreciation,EarningsPerShareBasicAndDiluted,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,FairValueAssetsLevel1ToLevel2TransfersAmount,FairValueAssetsLevel2ToLevel1TransfersAmount,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities,IncreaseDecreaseInContractWithCustomerLiability,IncreaseDecreaseInOperatingLeaseLiability,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestIncomeOther,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeaseRightOfUseAsset,OtherAccruedLiabilitiesCurrent,OtherLiabilitiesNoncurrent,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfConvertiblePreferredStock,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,StockholdersEquity,StockholdersEquityNoteStockSplitConversionRatio1,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,TemporaryEquityCarryingAmountAttributableToParent,TemporaryEquityLiquidationPreference,TemporaryEquitySharesAuthorized,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,DeferredTaxAssetsDeferredIncome,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwards,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsValuationAllowance,DefinedContributionPlanEmployerDiscretionaryContributionAmount,DepreciationAndAmortization,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCredits,GainLossOnSaleOfPropertyPlantEquipment,LeaseCost,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,OperatingLeaseLiability,OperatingLeasePayments,OperatingLeaseWeightedAverageDiscountRatePercent,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PropertyPlantAndEquipmentGross,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,ValuationAllowanceDeferredTaxAssetChangeInAmount
2021-06-30,2021-08-19,10-Q,"TSCAN THERAPEUTICS,Â INC.",TCRX,CIK0001783328,USD,3547000.0,3749000.0,368000.0,2088000.0,503000.0,503000.0,,130007000.0,110070000.0,104414000.0,,106197000.0,106792000.0,,0.0001,165210543.0,1682805.0,1419819.0,1000.0,,15616272.0,2540000.0,2500000.0,11746000.0,4560000.0,166000.0,,-7.69,1107000.0,6600000.0,0.0,0.0,,,2726000.0,,,,,,5000.0,30626000.0,130007000.0,20617000.0,,,,-10674000.0,13527000.0,-10679000.0,1575000.0,5211000.0,6185000.0,763000.0,238000.0,,,3873000.0,,,,,10451000.0,10801000.0,595000.0,-62119000.0,2848000.0,,,,,-60030000.0,,,63000.0,159411000.0,181879000.0,128053586.0,1387973.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-10,10-Q,"TSCAN THERAPEUTICS,Â INC.",TCRX,CIK0001783328,USD,5072000.0,4285000.0,445000.0,252029000.0,885000.0,885000.0,,204889000.0,187003000.0,181300000.0,,182312000.0,182907000.0,,,,,,,,,,,11967000.0,2844000.0,166000.0,,-0.8,1747000.0,10600000.0,0.0,0.0,,,4048000.0,,,,,,,30815000.0,204889000.0,22944000.0,,,,-15839000.0,18254000.0,-15842000.0,1620000.0,4791000.0,5830000.0,668000.0,236000.0,,0.0,4691000.0,,,,,11295000.0,14206000.0,595000.0,-77958000.0,2412000.0,,,,,174074000.0,,89647000.0,,,,,19875428.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-12-31,2022-03-09,10-K,"TSCAN THERAPEUTICS,Â INC.",TCRX,CIK0001783328,USD,1765000.0,6517000.0,949000.0,252933000.0,2516000.0,2516000.0,3136346.0,188107000.0,165654000.0,159668000.0,828000.0,161405000.0,166436000.0,131050000.0,,,,,,159411000.0,,,,11410000.0,1497000.0,166000.0,3328000.0,-4.17,2600000.0,10000000.0,0.0,0.0,0.0,0.0,13828000.0,10000.0,3234000.0,-6536000.0,-9000.0,2595000.0,,27329000.0,188107000.0,21343000.0,189668000.0,-9941000.0,-48677000.0,-48625000.0,58782000.0,-48641000.0,1651000.0,4392000.0,5491000.0,1012000.0,97000.0,9941000.0,0.0,4249000.0,89647000.0,99730000.0,291000.0,-48625000.0,11765000.0,44954000.0,5031000.0,-92158000.0,10141000.0,2516000.0,0.0,0.75,0.0079,160778000.0,,89646000.0,291000.0,,,,11662672.0,5083000.0,3526000.0,31007000.0,18742000.0,688000.0,5319000.0,99000.0,29507000.0,400000.0,3300000.0,0.0,0.21,-0.324,-0.01,0.083,0.041,,1300000.0,6932000.0,2075000.0,184000.0,730000.0,1812000.0,2131000.0,889000.0,6043000.0,1948000.0,0.08,0.0001,10000000.0,0.0,16848000.0,,1174000.0,5.74,0.0,0.0,15800000.0
